Lilly acquires biotech startup founded by WashU Med researchers
Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.
Author: Sharon
In the News: Startup founded by WashU alum raises $10M in Series A funding
It marks one of the largest funding rounds for a St. Louis startup in 2020.
SEI Lab awarded Kauffman grant to explore entrepreneurship, equity, mobility
SEI Lab has been awarded a $200,000 grant to explore and document how entrepreneurship affects equity and mobility.
In the News: St. Louis startup licenses COVID-19 vaccine developed at WashU
A COVID-19 vaccine developed at Washington University in St. Louis School of Medicine has been licensed by St. Louis biotech startup Precision Virologics.
Apply now: Fall 2020 Skandalaris Venture Competition
Applications are now open for the Skandalaris Venture Competition (SVC). Up to $22,500 in awards available.
WashU-alum startup Open Door acquired by Social Capital
Opendoor, cofounded by WashU alum JD Ross, will gain a $1 billion infusion in an acquisition that values the company at nearly $5 billion.
In the News: Saving lives with AR
More great ink for Washington University in St Louis inventors Jen and Jon Silva.
In the News: WashU innovator Morgan DeBaun on Black founders and venture capital
Washington University in St. Louis alum and entrepreneur Morgan DeBaun talks about venture-capital funding for Black founders.
Sticky post
WashU Med develops COVID-19 saliva test
The new test is faster and simpler than nasal and oral swab tests and enables screening on a massive scale.